300086.SZ · 康芝药业
China A-shares · RS rating 5 · As of 2026-10-14
| Price | 5.17 CNY |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 5 / 28 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 12 / 18 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -50.0% |
| Distance from 52-week high | +62.3% |
| Market cap (USD) | $373.7M |